Balchem Corp
BCPC
292 hedge funds and large institutions have $4.35B invested in Balchem Corp in 2023 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 95 increasing their positions, 106 reducing their positions, and 36 closing their positions.
1,683% more call options, than puts
Call options by funds: $6.37M | Put options by funds: $357K
23% more capital invested
Capital invested by funds: $3.55B → $4.35B (+$800M)
2.78% more ownership
Funds ownership: 88.8% → 91.59% (+2.8%)
8% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 36
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less funds holding
Funds holding: 293 → 292 (-1)
10% less repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 106
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$82.2M |
| 2 |
Corient Private Wealth
Miami,
Florida
|
+$32.9M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
+$27.6M |
| 4 |
BlackRock
New York
|
+$24.3M |
| 5 |
JP Morgan Chase
New York
|
+$10.6M |
Top Sellers
BCPC Hedge Fund Activity: Q4 2023 in Review
292 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Balchem Corp (BCPC) for Q4 2023, worth a combined $4.35B — up 23% from $3.55B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new BCPC positions and 36 closed out — a net gain of 3 holders — while 95 added to existing stakes and 106 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $82.2M. The largest seller was Segall Bryant & Hamill, cutting an estimated $32.5M.
- 292 institutional investors held Balchem Corp (BCPC) as of Q4 2023, down from 293 in Q3 2023.
- Funds reported $4.35B of Balchem Corp stock for Q4 2023, up 23% quarter-over-quarter.
- 39 funds opened new Balchem Corp positions in Q4 2023 and 36 closed out, a net change of +3 holders.
- The largest Balchem Corp buyer in Q4 2023 was Morgan Stanley, an estimated $82.2M added.
- The largest Balchem Corp seller in Q4 2023 was Segall Bryant & Hamill, an estimated $32.5M sold.
Based on aggregated 13F filings for Q4 2023.